Logo image of BTX

BLACKROCK TECH & PRIV EQTY (BTX) Stock Price, Quote, News and Overview

NYSE:BTX - New York Stock Exchange, Inc. - US09260Q1085 - Currency: USD

7.14  +0.04 (+0.56%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BTX. BTX was compared to 0 industry peers in the Unkown industry. BTX has a bad profitability rating. Also its financial health evaluation is rather negative. BTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BTX was profitable.
BTX had a positive operating cash flow in the past year.
In multiple years BTX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: BTX reported negative operating cash flow in multiple years.
BTX Yearly Net Income VS EBIT VS OCF VS FCFBTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

Industry RankSector Rank
ROA 1.6%
ROE 1.61%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTX Yearly ROA, ROE, ROICBTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

The Operating Margin and Gross Margin are not available for BTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 655.74%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTX Yearly Profit, Operating, Gross MarginsBTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

3

2. Health

2.1 Basic Checks

BTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BTX Yearly Shares OutstandingBTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
BTX Yearly Total Debt VS Total AssetsBTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 48.23 indicates that BTX is not in any danger for bankruptcy at the moment.
The Debt to FCF ratio of BTX is 0.00, which is an excellent value as it means it would take BTX, only 0.00 years of fcf income to pay off all of its debts.
BTX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for BTX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 48.23
ROIC/WACCN/A
WACCN/A
BTX Yearly LT Debt VS Equity VS FCFBTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

2.3 Liquidity

BTX has a Current Ratio of 0.10. This is a bad value and indicates that BTX is not financially healthy enough and could expect problems in meeting its short term obligations.
BTX has a Quick Ratio of 0.10. This is a bad value and indicates that BTX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
BTX Yearly Current Assets VS Current LiabilitesBTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

BTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.91%.
Looking at the last year, BTX shows a very strong growth in Revenue. The Revenue has grown by 23.65%.
The Revenue for BTX have been decreasing by -22.63% on average. This is quite bad
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1633.33%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%-20%

3.2 Future

Based on estimates for the next years, BTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.02% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTX Yearly Revenue VS EstimatesBTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BTX Yearly EPS VS EstimatesBTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.00 indicates a quite expensive valuation of BTX.
BTX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.52.
BTX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 42
Fwd PE N/A
BTX Price Earnings VS Forward Price EarningsBTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.49
EV/EBITDA N/A
BTX Per share dataBTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BTX does not grow enough to justify the current Price/Earnings ratio.
BTX's earnings are expected to grow with 18.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y18.02%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKROCK TECH & PRIV EQTY

NYSE:BTX (6/6/2025, 8:04:01 PM)

7.14

+0.04 (+0.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2022-08-11/amc
Earnings (Next)11-17 2022-11-17/bmo
Inst Owners45.28%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap0
Analysts80
Price TargetN/A
Short Float %0.13%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP513.89%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.08069)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 42
Fwd PE N/A
P/S 277.02
P/FCF 5.49
P/OCF 5.49
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0.17
EY2.38%
EPS(NY)-7.99
Fwd EYN/A
FCF(TTM)1.3
FCFY18.21%
OCF(TTM)1.3
OCFY18.21%
SpS0.03
BVpS10.5
TBVpS10.49
PEG (NY)1.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 1.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 655.74%
GM N/A
FCFM 5045.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 769.44%
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 48.23
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1633.33%
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%-20%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.65%
FCF growth 3YN/A
FCF growth 5Y178.61%
OCF growth 1Y27.65%
OCF growth 3YN/A
OCF growth 5Y151.66%